MOTS-c in muscle, fat and stressed cells
The appeal is obvious: a peptide from the cell’s energy machinery. The surprise is how differently the tissues answered it.
Opposite CK2 responses
The 2024 muscle study combined cell-free binding tests with experiments in young, aged, high-fat-fed and immobilised mice. It identified CK2 as a direct target of MOTS-c. CK2 activity increased in muscle and decreased in fat, alongside improved glucose uptake and protection against muscle wasting in the mouse experiments.
I relish this tissue-level disagreement. A single target has acquired a different direction of change depending on the tissue. Describing the whole result as more energy would erase the very feature that makes it worth understanding.
MOTS-c contains sixteen amino acids and is encoded in mitochondrial DNA. Mitochondria are the cell structures that turn fuel into usable energy. The review of MOTS-c, stress and metabolism places this small peptide within a much wider system of fuel sensing and cellular adaptation.
Exercise experiments in mice
In the exercise and ageing experiments, physical activity induced naturally produced MOTS-c, and added peptide improved running capacity, grip strength and gait in mice. The work included mice aged 2, 12 and 22 months, with particularly striking performance findings in the aged animals.
Grip and running capacity are useful because the animal has to perform a task. I favour the mouse being asked to grip or run over another isolated marker. The ages and conditions still matter: an old mouse, an immobilised mouse and a healthy person looking for more stamina pose different questions.
These studies supply no validated human half-life, bioavailability or treatment schedule. The mouse experiments leave human benefit and safety to be tested directly.
A peptide in the nucleus
During metabolic stress, MOTS-c moved into the nucleus of cultured human and mouse cells and helped regulate protective gene activity. The nucleus houses most of the cell's DNA. A peptide encoded by mitochondrial DNA was participating in the regulation of that other genetic compartment.
That journey is an appealing biological solution to an energy shortage. It also takes place in a particular experimental world: cultured cells under stress. Cell survival machinery can suggest useful research without predicting how much stronger, more energetic or longer-lived a person would become.
Natural MOTS-c during dialysis
The human cohort followed 94 people receiving chronic haemodialysis for a median 26.5 months. Their circulating MOTS-c was associated with a combined outcome of death and non-fatal cardiovascular events and added information to a risk model. The team measured peptide already present in their bodies.
No participant received MOTS-c as a treatment in that study. It therefore addresses a blood marker in people with severe kidney disease. It supplies neither a treatment benefit nor a direction for self-treatment in someone with fatigue.
MOTS-c has no FDA approval and no completed human efficacy or safety trial in this record. Community reports are too sparse to establish a consistent benefit or harm; a quiet discussion is weak reassurance. Product identity and purity add uncertainty outside formal research, and anti-doping rules prohibit its use in tested sport. For me, the muscle–fat disagreement earns further investigation precisely because the human answer is still open.